These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38483602)

  • 1. Percutaneous Image-Guided Cryoablation of Endophytic Renal Cell Carcinoma.
    Jensen CG; Dybdahl M; Valtersson J; Mussmann BR; Duus LA; Junker T; Pietersen PI; Lund L; Welch BT; Graumann O
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):453-461. PubMed ID: 38483602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.
    Murray CA; Welch BT; Schmit GD; Schmitz JJ; Weisbrod AJ; Callstrom MR; Welch TL; Thompson RH; Kurup AN; Boorjian SA; Atwell TD
    Urology; 2019 Nov; 133():151-156. PubMed ID: 31415781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
    Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
    Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer.
    Duus LA; Junker T; Rasmussen BS; Bojsen JA; Pedersen AL; Anthonsen A; Lund L; Pedersen M; Graumann O
    Acta Radiol; 2023 Feb; 64(2):814-820. PubMed ID: 35297745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous image-guided cryoablation with temporary balloon occlusion of the renal artery for the treatment of central renal tumors.
    Autrusseau PA; Boatta E; Cazzato RL; Auloge P; Mayer T; Weiss J; Koch G; Caudrelier J; De Marini P; Gangi A; Garnon J
    Diagn Interv Imaging; 2022 Nov; 103(11):510-515. PubMed ID: 35934617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes.
    Kim DK; Won JY; Park SY
    Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of cryoablation for biopsy-proven T1 stage renal cell carcinoma.
    Song S; Yang Q; Gu C; Yu G; Hua B; Gu X; Wang L; Wang Z; Shi G; Xu B
    World J Surg Oncol; 2022 Sep; 20(1):284. PubMed ID: 36064369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
    Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
    BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.